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Introduction
Coronary artery bypass grafting (CABG) is a method of choice in treatment of patients with severe multi-vessel coronary artery disease (CAD) [1] . In majority of cases, it significantly improves the quality of life, alleviating the patient from coronary symptoms [2, 3] . A long-term outcome in CABG patients depends, however, on graft patency rate as well as atherosclerotic progression in native coronary arteries. It is commonly accepted arterial grafts, particularly left internal mammary artery implanted to the left anterior descending artery, result in higher late patency rates as compared to the venous conduits [4] . Unfortunately, the adequate arterial conduits are not always available, thus more easily harvested saphenous vein (SV) grafts are still widely used.
There are at least 3 principal mechanisms leading to venous graft failure. They include thrombosis, intimal hyperplasia and accelerated atherosclerosis [5] . Among others, vascular smooth muscle cells (SMCs) are believed to play a crucial role in pathogenesis of the late graft occlusion [6] . Secondary to locally distributed stimulating agents, they are able to migrate through internal elastic lamina to tunica intima, proliferate and secrete extracellular matrix [7] . It results in progressive neointimal formation that might lead to the decisive narrowing of the grafts and clinically CAD progression or angina recurrence and, in some cases, acute coronary syndromes (ACSs) [8] .
On the other hand, the populations of both arterial and venous SMCs were reported to be heterogeneous and manifest at least 2 phenotypes: elongated/spindle-like cells or epithelioid/rhomboid shaped cells that expressed a variant proliferative and chemotactic activity [9, 10] . Subtypes of SMCs were also characterized by altered expression of smooth muscle proteins such as smooth muscle myosin heavy chain (SM-MHC), calponin (CALP) and cytokeratin 8 (CK8) that were associated with various stages of cellular differentiation [10] . SM--MHC and CALP are expressed predominantly in the mature SMCs while CK8 expression is typical for fetal and poorly differentiated cells [10] [11] [12] .
In line with the above, the aim of the present study was to evaluate expression of selected cytoskeletal proteins in tunica media of SV grafts obtained from CABG patients and correlate procured results to late venous graft fate observed in these patients.
Methods

Study group
Local Ethics Committee has approved a research protocol (No.1201/08) and an informed written consent from each study participant was obtained. 
Operation procedure and sample collection
All surgeries were performed from median sternotomy. A part of them were accomplished on the beating heart (off-pump coronary artery bypass, OPCAB) with the routine use of tissue stabilizer (Octopus 4) and intracoronary shunts (ClearView) (both, Medtronic Inc., USA). The others were carried out in the extracorporeal circulation in the moderate hypothermia (conventional CABG) ( Table 1) . SV was obtained through a full-length thigh incision over its course [13] . Key points included minimal manipulation of the graft ("no-touch" technique), avoiding of extensive dilation of the conduits, using low-intensity electrocautery and control of the branches with stainless-steel vascular clips. In all the cases, the distal part of harvested SV segment (at least 1.5-2.0 cm in length) was saved for subsequent laboratory studies.
Immunohistochemistry
The venous segments were carefully rinsed with 0.9% NaCl at the room temperature, slightly dilated and fixed in Bouin's solution for 2-3 h. They were dehydrated and then embedded in paraffin blocks by means of routine procedure. Eventually, they were cut into 5-mm sections on a semi-automatic rotary microtome (Leica RM 2145, Leica Microsystems, Nussloch, Germany). Each sample of the SV (taken from separate patients) was cut into approximately 30 paraffin sections. All of the immunohistochemical (ICC) analyses employed StreptABComplex/HRP method modified by use of biotinylated tyramide (Dako Catalyzed Signal Amplification System, Peroxidase, K1500, DakoCytomation A/S, Glostrup, Denmark) as previously described [14] . After deparaffinization with xylene and gradual rehydratation the endogenous peroxidase activity was blocked with 10% hydrogen peroxide (v/v) treatment for 10 min. At the consecutive stages of ICC, the indirect ABC technique was performed, with the following steps: (1) preincubation with the appropriate normal goat serum in phosphate buffered solution for 30 min at room temperature; (2) incubation with the first specific antibody, overnight at 4°C in a hybridization chamber; (3) incubation with the secondary antibody for 60 min at room temperature; (4) final antigen-antibody complexes staining using 0.5% 3-3' diaminobenzidine (DAB; Sigma Chemical Co., St. Louis, MO).
The following monoclonal mouse anti-human specific antibodies were used: anti-a-smooth muscle actin (a-SM actin) (M0851), anti-SM-MHC (MAB13431), anti-CALP (M3556) (all from DakoCytomation A/S, Glostrup, Denmark) and anti-CK8 (ab9023; Abcam, Cambrigde, UK).
The intensity of cytoplasmic protein expression was assessed using the semi-quantitative immuno-reactive score (IRS) scale according to Remmele and Stenger [15] . It takes into account the percentage of positive cells (scale from 0 to 4) and the intensity of the color reaction (scale from 0 to 3) and final score that ranges from 0 to 12 is a product of points given for individual traits (Table 2) . On the base of IRS, cytoplasmic protein expression was defined as negative (IRS 0-1), positive weak (IRS 2-3), positive moderate (IRS 4-6) or strong (IRS 7-12) [16] . All tissue sections were analyzed under AxioImager Z.1 light microscope and selected pictures were captured with attached AxioCam MRc5 digital camera (Carl Zeiss MicroImaging GmbH, Göttingen, Germany).
ICC analysis of proteins expression in each vessel section was done within 10 representative microscopic fields (× 200 magnification). Intensity of ICC reaction was evaluated independently by 2 pathologists on coded samples. Additionally, all of ICC analyses included the negative controls that consisted of specimens incubated with nonimmune IgG1 (X-0931, DakoCytomation A/S, Glostrup, Denmark) and sections in which the primary or secondary antibody was omitted.
Evaluation of late coronary outcome
The primary clinical endpoint of this prospective study included any clinical form of CAD progression that occurred throughout post-discharge follow-up. It confines all ACSs cases (unstable angina, myocardial infarction (MI) with or without ST seg- ment elevation, respectively STEMI or NSTEMI) as well as recurrence or progression of stable angina according to Canadian Cardiovascular Society (CCS) classification. Patients CCS status was assessed at the end of postoperative rehabilitation (usually 4 weeks after surgery) and then at the end of follow-up. Additionally, at the end of follow--up, all aortocoronary bypass grafts were examined by means of coronary angiography (n = 187) or computed tomography angiography (CTA) with multi-slice detector (n = 23). CTA was offered only to subject who withdrew consent for follow-up invasive coronary examination. Hemodynamically significant SV disease was defined as graft lumen restriction exceeded 70% (the primary angiographic endpoint).
Clinical data and SMCs protein expression in patients with lesions in venous bypass grafts
Selected preoperative clinical and intraoperative data were compared between groups of patients with and without significant venous graft disease in the last follow-up coronary angiography: SVGD(+) vs. SVDG(-), respectively. Moreover, expression of SMCs proteins such as SM-MHC, CALP and CK8 in SV segments obtained from patients of both subgroups was also recalculated and analyzed.
Data management and statistical analysis
Initially, all continuous variables were estimated for normality with the Shapiro-Wilk W test. When they complied with a normal distribution they were expressed as the mean ± standard deviation and then they were compared using un--paired t test. Non-parametric continuous variables expressed as median (25 th -75 th percentile) were compared using Mann-Whitney U test. Categorical data were expressed as number (n) and percent (%) or median (25 th -75 th percentile) and were compared employing Pearson c 2 test or Kruskal-Wallis test. A p value < 0.05 was considered to be as statistically significant.
The univariate followed by multivariate logistic regression analysis of the several variables (demographic, clinical, immunohistochemical) were performed to identify predictors for accelerated venous graft disease development (angiographic endpoint of the study). Only variables with a p value of < 0.2 by means of univariate regression model were entered into a multivariate logistic regression one. Variables revealed to be significant (p < 0.05) at the latter model were considered to be independent predictors for accelerated graft failure. The p values and odds ratios (ORs) with corresponding 95% confidence intervals (95% CI) were presented. [PCI] , arterial hypertension, diabetes mellitus treated with insulin, hyperlipidemia, peripheral vascular disease), severity of CAD (younger age of CABG necessity [£ 50 years], left main stenosis, three vessels disease) and these derived from ICC analysis of SMCs proteins (both weak and strong expressions of SM-MHC, CALP and CK8) were entered into logistic regression analysis.
Freedom from CAD progression was estimated using Kaplan-Meier method. All statistical analysis were carried out using Statistica 9.0 for Windows (StatSoft, Inc., Tulsa, OK, USA).
Results
Clinical observation: Late coronary outcome
Eight individuals enrolled to the study protocol were discarded from both clinical and angiographic analysis of late coronary outcome. Six of them died either soon after surgery (due to postcardiotomy low cardiac output syndrome (Fig. 2) , including 37 patients with clinical symptoms of CAD progression. SVGD development was usually accompanied by progression of atherosclerosis in the native coronary arteries. Only in 1 case culprit lesions in the native vascular bed but not in bypass grafts were regarded as reason of marked clinical CAD deterioration.
Bartłomiej Perek et al., CK8: Factor of unfavorable prognosis ments (n = 60). In 10 (4.6%) cases its expression was recognized as positively strong (IRS ≥ 7). In the rest of cases, SM-MHC expression was accepted as weakly or moderately positive. If preent, SM-MHC was localized regularly within the whole SMC, except of nucleus territory.
CALP was expressed in all studied SV transplants. In majority of cases (n = 200, 91.3%), its cytoplasmic presence within SMCs was regarded as moderately or strongly positive. It was not seen within tunica adventitia or loose connective tissue present in tunica media.
In more than 50% of analyzed SV transplants, there were no expression of CK8 (IRS 0-1). Otherwise, only in 34 cross-sections of SV grafts (15.6%) it was assessed as strongly positive in tunica media. Similarly to SM-MHC expression, CK8 occupied the whole SMCs cytoplasm except of nucleus.
Comparison of patients with and without venous graft failure
Generally, SVGD(+) patients at the time of surgery were significantly younger as compared to SVGD(-) subjects (57.8 ± 8.3 vs. 63.6 ± 8.5, p < 0.001). No significant differences in prevalence of commonly accepted risk factors for atherosclerosis development (obesity, arterial hypertension, diabetes) as well as postoperative medical therapy 
Expression of SMCs proteins
ICC expression of a-SM actin was estimated in all the studied SV grafts. Its expression was present within SMCs cytoplasm and referred to IRS 9 or 12 regardless postoperative clinical course of CABG patients (data not shown). Interestingly SM-MHC was not expressed in 27.5% of SV seg-(statins, acetylsalicylic acid [ASA]) were found between groups (Table 3 ). Statistical analysis of SMCs cytoskeletal expression pattern predicting development of atherosclerotic plaques in SV grafts revealed the risk of critical transplant occlusion is higher in CK8-positive (Fig. 3) and CALP-weak positive study participants. All the detailed information are summarized in Table 3 .
Regression analysis
Nine variables (age £ 50 years, gender, previous PCI, three vessels disease, SM-MHC IRS ≥ 7, weak CALP expression, CALP IRS ≥ 7, no or weak CK8 expression and CK8 IRS ≥ 7) reached p < 0.2 in the univariate model and were then analyzed in the multivariate one. That latter one revealed a strong expression of CK8 (OR 1.90, 95% CI 1.11--7.76, p = 0.037) and weak of CALP (OR 1.40, 95% CI 1.04-6.57, p = 0.042) were the independent risk factors for SVGD development. Otherwise, the strong expression of both CALP and SM-MHC as well as lack of CK8 were associated with low risk for restricting lesions development in venous aortocoronary grafts and, in consequence, favorable CABG long-term outcome. The results of logistic regression model to indentify independent risk factors for late SVGD development are presented in Table 4 .
Discussion
The main purpose of CABG is to bridge over lesions compromising adequate flow in the coronary arteries and thus to improve myocardial perfusion. Clinically CABG patients usually experience marked improvement in quality of life, better physical performance and relief from angina [17] . This effect persists unless development of graft disease or rapid progression of atherosclerosis in the native coronary arteries [18] . In our study it was shown the majority of CABG patients presented significant improvement in CAD symptom control at least 3-4 years after surgery. However, a subset of CABG individuals with post-discharge CAD deterioration had been growing systematically by the end of follow-up period (Fig. 1) . The last follow-up angiographic examination revealed CAD symptoms recurrence and progression were associated with SVGD. However, it must be stressed that 7 patients reached the primary angiographic endpoint without any clinical manifestation of CAD progression. All of them had diabetes treated with insulin for at least 5 years. Thus it is likely that the clinical and angiographic endpoints discrepancy may have resulted from diabetes-related cardiac autonomic neuropathy [19] . Statistical analysis revealed that SVGD(+) subjects were markedly younger than SVGD(-). It may be related to more aggressive atherosclerosis in younger CAD patients [20] . Relatively young age was found significantly predictive of angina recurrence not only after CABG but also after PCI [21] . Moreover, we have shown recently, in the elderly CABG individuals both SV wall and tunica media were hypotrophic [22] . However, SVGD(+) and SVGD(-) patients did not differ to one another with respect to prevalence of such factors for atheroma formation as obesity, diabetes mellitus, hyperlipidemia, arterial hypertension or peripheral vascular disease. It could not rule out that aforementioned factors would be of importance in longer follow--up (e.g. 10-15 years after surgery). Moreover, the same postoperative medical management, including statins and ASA was applied. Thus it is likely that other undisclosed factors may also have a potent impact on long-term performance of venous aortocoronary bypass grafts.
It was proved previously, a long-term clinical and angiographic success of SV as aortocoronary bypass graft was determined by the inevitable biological process called "arterialization" [23, 24] . SMCs and fibroblasts are the main effector cells of arterialization, and in the consequence crucial for long-term fate of grafts. In our study we evaluated expression of cytoskeletal SMCs proteins such as a-SM actin, SM-MHC, CALP and CK8 in the SV tunica media. a-SM actin was employed to identify SMCs within SV tunica media as it usually detected in all stages of SMCs development [10] . In all SV specimens a-SM actin positive cells within tunica media were found. SM-MHC and CALP are usually expressed in well differentiated, mature, contractile phenotype SMCs [10, 12] . In our study we found SVGD(+) patients had no strong SM--MHC expression and only 6 (14%) cases of them presented strong expression of CALP. Contrary to them, among SVGD(-) individuals more than 40% of medial SMCs manifested strong CALP immunostaining. Another examined cytoskeletal SMCs protein, CK8 is not usually detected in normal, well differentiated contractile SMCs. It has been found previously in both immature, fetal or in synthetic SMCs that could migrate from tunica media into the neointima [11, 25] . Interestingly, although we examined SV segments obtained from the adults we detected positive strong expression of CK8 in 50% (!!!) of SVGD(+) individuals while in much less than 10% of SVGD(-) subjects. Additionally, aforementioned findings were supported by logistic regression model that revealed different expressions of venous medial smooth muscle proteins associated with various stages of differentiation were of paramount importance for long-term CABG outcome. Strong expression of CK8 in medial SMCs and weak expression of CALP were confirmed to be the independent risk factors for unfavorable outcome after CABG with the use of SV conduits. Thus degree of SMCs differentiation within SV tunica media has impact on their ability to respond to various aforementioned biologically active chemo-attractant and mitogenic molecules. Higher representation of poorly differentiated, probably synthetic SMCs is linked to accelerated development of culprit lesions in venous aortocoronary bypass grafts. This finding should provoke the following question, why in some adult patients expression of CK8, fetal cytoskeletal protein, is so strong while CALP and SM-MHC markedly diminished. It was proved the contractile, mature SMCs may undergo dedifferentiation in synthetic phenotype under pathological circumstances such as ischemia, repetitive injuries (mechanical, inflammatory etc.), prolonged exposure to growth factors (e.g. VEGF) in the experimental models but also in atherosclerotic lesions [26, 27] . This phenotypic modulation is usually accompanied by a loss of contractile function together with progressively impaired expression of cytoskeletal markers of maturity. This process of SMCs change seems to be reversible (reversibly synthetic SMCs) but if causative factor persists SMCs may become incapable of return or return to the contractile state is incomplete (irreversibly synthetic cells) [27] . Thus, it might be some of CK8 strong positive and CALP weak positive SMCs presented irreversibly synthetic phenotype that featured high potential to biological activity (i.e. proliferation, migration etc.).
Our study supports earlier findings that medial SMCs in SV wall do not represent homogenous population in terms of not only morphology (different shapes of both cells and their nuclei) but also their biological properties (variations in response to potent mitogenic molecules) [10, 28] . We have also proved this biological variability had significant impact on CABG outcome with the use of SV grafts.
The findings of this study should encourage surgeons in cooperation with histologists to work out a simple test to identify SV segments with high likelihood of the accelerated venous graft disease and unfavorable outcome after CABG. Positive result of the screening method would disqualify SV segment from use and encourage surgeon to employ alternative sources of the conduits. 
Conclusions
Strong expression (IRS ≥ 7) of CK8 and weak of calponin (IRS 2-3) in tunica media of SV transplants may be useful markers in identification of venous segments exposed to accelerated atheroma formation and, in consequence, venous graft failure. In the future, assessment of these proteins expression it will enable to select the groups of CABG patients who will benefit particularly from SV aortocoronary grafts.
